• Sectors we work in banner(2)

    Quick Reads

The ongoing fight against fakes

When counterfeit goods are mentioned, initial thoughts may be of luxury items such as handbags copied in a far cheaper and more accessible form. Hidden behind such goods is the harm done to rights holders, who have invested time and money developing and producing a product, and the organised crime and downstream harm caused by such counterfeit items. However, other products are also counterfeited and the impact to the consumer can be more immediate and dangerous – electrical goods and pharmaceuticals are two categories that are also frequently copied.

EUROPOL recently coordinated the fourth edition of Operation SHIELD, a global effort to tackle fake pharmaceuticals.  The operation saw 1,284 individuals charged and took fake medicines worth EUR 64 million off EU markets.

The sale of fake pharmaceuticals, and illegal trafficking of pharmaceuticals, continues to be a growing issue and is a significant public health problem.

The Internet remains an enticing outlet for suppliers of counterfeit goods and social media is a current popular forum for selling counterfeit and illegally sold medicines. Of key importance is educating users of social media, particularly younger generations, on the significant safety risks associated with sourcing pharmaceuticals outside the legitimate supply chain. As consumers, it is key that we question what the item is and where it has come from.

Brand owners should seek to protect and enforce their trade mark rights to help curb the proliferation of counterfeit products worldwide and protect consumers. 

The EUROPOL press release makes for impressive reading but the fight against counterfeiters is ongoing. Vigilance by consumers and brand owners, and protection of important intellectual property, are key.

 

Medicines are often counterfeited in underground laboratories without any regulation or safety measures in place. Counterfeit products created under such circumstances do not produce the desired effect; in the best case scenario the patient remains untreated, however such products can cause serious health issues or be potentially lethal.

Our thinking

  • Key Developments in International Arbitration for 2026

    Dalal Alhouti

    Quick Reads

  • Agricultural policy review 2025: Key changes and what to expect in 2026

    Maddie Dunn

    Insights

  • Leasehold and Freehold Reform Act 2024: Government launches consultation to switch on provisions relating to estate management charges

    Laura Bushaway

    Quick Reads

  • M&A in UK financial services - will mega-deals in 2025 lead to more mid-market activity in 2026?

    Mike Barrington

    Quick Reads

  • A new prospectus regime and other developments impacting UK Equity Capital Markets in 2026

    Andrew Collins

    Insights

  • The Introduction of Aquis Support Services – 19 January 2026

    Emily Dobson

    Insights

  • POATR - What type of securities does the new regime apply to?

    Emily Dobson

    Quick Reads

  • Infosecurity Magazine quotes Mark Bailey on the Cyber Security and Resilience Bill

    Mark Bailey

    In the Press

  • Hannah Catt writes for Tax Adviser on the implications of the newly introduced high value council tax surcharge in the UK

    Hannah Catt

    In the Press

  • eprivateclient quotes Dominic Lawrance on rumours surrounding potential UK government plans to attract HNW investors

    Dominic Lawrance

    In the Press

  • UK Living Sector 2026: Regulatory pressures, new trading platforms and more accessible public markets

    Sarah Wigington

    Insights

  • Drip Pricing and Enforcement: How the DMCC Act is Changing the Rules

    Mark Dewar

    Insights

  • The Standard quotes William Marriott on the impact of the newly introduced 'mansion tax' in the UK

    William Marriott

    In the Press

  • Amenity Space in UK Office Buildings: Why It Matters and What Tenants Need to Consider

    Lynsey Inglis

    Insights

  • UK Hotels Sector 2026: Renovations, AI and Experience‑Led Stays

    James Broadhurst

    Insights

  • Charles Russell Speechlys grows Real Estate team with the appointment of UK and Italian market expert Chiara Del Frate

    Robin Grove MIoL

    News

  • Investment Week quotes Greg Stonefield on whether 2026 will be the year of London IPOs

    Greg Stonefield

    In the Press

  • Compliance Week quotes Abigail Rushton on the UK’s anti-corruption strategy and compliance lessons for companies and advisors

    Abigail Rushton

    In the Press

  • When Saying “No” to Mediation Is Reasonable: Guidance from Grijns v Grijns

    Bella Preece

    Quick Reads

  • TechRound quotes Charlotte Hill and Vadim Romanoff on their 2026 cryptocurrency and digital assets predictions

    Charlotte Hill

    In the Press

Back to top